At Southern Stem Cell Institute we believe combining stem cell therapy with Hyperbaric Oxygen Therapy (HBOT) to treat patients can significantly increase the concentration of circulating stem/progenitor cells within the peripheral circulation system.
Having sufficient levels of oxygen will allow faster healing to take place. The Hyperbaric oxygen chamber increases the rates of oxygen in the body so that it is dissolved into the body at a rapid healing to occur that enables fibroblasts (tissue cells), capillaries (circulatory), osteoblasts (bone cells) and stem cells to be stimulated.
This combination of treatments can increased the number of stem cells in the body and have the ability provide enhanced and accelerated physiological repair to patients with degenerative disorders.
What is HBOT?
Normal air contains 21 per cent oxygen at sea level, while patients immersed in a hyperbaric oxygen chamber will consume 100 per cent oxygen.
When consumed normally above ground, this level of oxygen provides only the red blood cells with stimulation. However, high levels of oxygen consumed in the chamber dissolve into all the body’s fluids, including plasma and central nervous system fluids. Once consumed, this oxygen stimulates the levels of DNA present in each cell, helping to accelerate the healing process substantially.
As HBOT is an FDA-regulated process, the treatment has to take place in a controlled environment to ensure patients are safe as they experience a change in atmospheric pressure and heightened levels of oxygen.